Bluebee was founded by Prof. Dr. Koen Bertels as a Spin-Off by the Technical University Delft and Imperial College London.

The company provides accelerated hardware solutions and a cloud-based genomics analytics suite to address the immense opportunity of processing and analysing the ever-increasing raw DNA-data flow. The field of oncology remains a core focus, while non-human DNA applications are being explored.

The strong management team with a solid track record in data flow management and securitisation complements the academic expertise of Bluebee.

A shared vision on DNA analysis with CEO and serial entrepreneur Hans Cobben, led to a substantial investment by Buysse & Partners in 2015.